• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Role of lupus anticoagulant and von Willebrand factor in chronic reactive endotheliitis in COVID-19.

作者信息

López Reboiro Manuel Lorenzo, Suárez Fuentetaja Rebeca, Gutiérrez López Raquel, Ares Castro-Conde Beatriz, Sardiña González Cristina, Navarro Menéndez Inés, Pereyra Barrionuevo Marco Francisco, Alves Pérez M Teresa, López Castro José

机构信息

Department of Internal Medicine, Hospital Público de Monforte, Lugo, Spain.

Hematology Section, Department of Internal Medicine, Hospital Público de Monforte, Lugo,Spain.

出版信息

J Infect. 2021 Jun;82(6):e27-e28. doi: 10.1016/j.jinf.2021.03.006. Epub 2021 Mar 15.

DOI:10.1016/j.jinf.2021.03.006
PMID:33737115
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7959681/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0264/7959681/1a89ca954cc1/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0264/7959681/1a89ca954cc1/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0264/7959681/1a89ca954cc1/gr1_lrg.jpg

相似文献

1
Role of lupus anticoagulant and von Willebrand factor in chronic reactive endotheliitis in COVID-19.狼疮抗凝物和血管性血友病因子在新冠病毒肺炎慢性反应性内皮炎中的作用
J Infect. 2021 Jun;82(6):e27-e28. doi: 10.1016/j.jinf.2021.03.006. Epub 2021 Mar 15.
2
Interference from lupus anticoagulant on von Willebrand factor measurement in splenic marginal zone lymphoma: a case report.狼疮抗凝物对脾边缘区淋巴瘤中血管性血友病因子检测的干扰：一例报告
Blood Coagul Fibrinolysis. 2015 Jun;26(4):454-7. doi: 10.1097/MBC.0000000000000240.
3
Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality.循环血管性血友病因子和高分子量多聚体作为内皮损伤标志物可预测COVID-19患者的院内死亡率。
Angiogenesis. 2021 Aug;24(3):505-517. doi: 10.1007/s10456-020-09762-6. Epub 2021 Jan 15.
4
A COVID Constellation: A Case of Transverse Myelitis and Acquired von Willebrand Syndrome.COVID 伴发症：一例横贯性脊髓炎和获得性血管性血友病。
J Investig Med High Impact Case Rep. 2022 Jan-Dec;10:23247096221109205. doi: 10.1177/23247096221109205.
5
Increased von Willebrand factor antigen and low ADAMTS13 activity are related to poor prognosis in covid-19 patients.血管性血友病因子抗原增加和ADAMTS13活性降低与新冠病毒肺炎患者的不良预后相关。
Int J Lab Hematol. 2021 Aug;43(4):O152-O155. doi: 10.1111/ijlh.13476. Epub 2021 Jan 27.
6
Acquired von Willebrand's syndrome in association with a lupus-like anticoagulant corrected by intravenous immunoglobulin.
Am J Hematol. 1994 Jun;46(2):141-6. doi: 10.1002/ajh.2830460216.
7
ADAMTS 13 deficiency is associated with abnormal distribution of von Willebrand factor multimers in patients with COVID-19.ADAMTS 13缺乏与新型冠状病毒肺炎患者血管性血友病因子多聚体的异常分布有关。
Thromb Res. 2021 Aug;204:138-140. doi: 10.1016/j.thromres.2021.02.008. Epub 2021 Feb 9.
8
Etiology and Management of Bleeding during ECMO in a COVID-19 Patient.一名新冠肺炎患者体外膜肺氧合期间出血的病因及处理
J Atheroscler Thromb. 2021 Apr 1;28(4):402-403. doi: 10.5551/jat.61747. Epub 2021 Jan 23.
9
Lupus Anticoagulant in Patients with Covid-19.新冠病毒肺炎患者中的狼疮抗凝物
N Engl J Med. 2020 Nov 5;383(19):1893. doi: 10.1056/NEJMc2027508. Epub 2020 Oct 23.
10
Complementary Sets of Autoantibodies Induced by SARS-CoV-2, Adenovirus and Bacterial Antigens Cross-React with Human Blood Protein Antigens in COVID-19 Coagulopathies.SARS-CoV-2、腺病毒和细菌抗原诱导的互补自身抗体与 COVID-19 凝血障碍中的人血蛋白抗原发生交叉反应。
Int J Mol Sci. 2022 Sep 29;23(19):11500. doi: 10.3390/ijms231911500.

引用本文的文献

1
The COVID-19 Pandemic Was Associated with a Change in Therapeutic Management and Mortality in Heart Failure Patients.新冠疫情与心力衰竭患者治疗管理及死亡率的变化有关。
J Clin Med. 2024 Apr 29;13(9):2625. doi: 10.3390/jcm13092625.
2
The Dysregulation of the Monocyte-Dendritic Cell Interplay Is Associated with In-Hospital Mortality in COVID-19 Pneumonia.单核细胞与树突状细胞相互作用失调与COVID-19肺炎患者的院内死亡率相关。
J Clin Med. 2024 Apr 24;13(9):2481. doi: 10.3390/jcm13092481.
3
The Correlation Between sP-Selectin and Platelet Count in COVID-19 Patients in Referral Hospital, West Java Indonesia.

本文引用的文献

1
Post-coronavirus disease syndrome and disseminated microthrombosis: the role of the von Willebrand factor and antiphospholipid antibodies.新冠后综合征与弥漫性微血栓形成：血管性血友病因子及抗磷脂抗体的作用
Clinics (Sao Paulo). 2021 Mar 24;76:e2784. doi: 10.6061/clinics/2021/e2784.
2
Saddle pulmonary embolism and clot in transit in COVID-19 infection: a case report of catastrophic venous thromboembolism.新型冠状病毒肺炎感染中的鞍状肺栓塞及移行性血栓：一例灾难性静脉血栓栓塞病例报告
Eur Heart J Case Rep. 2020 Dec 7;4(6):1-6. doi: 10.1093/ehjcr/ytaa437. eCollection 2020 Dec.
3
Post-COVID-19 Syndrome (PC19S): Chronic Reactive Endotheliitis and Disseminated Vascular Disease.
印度尼西亚西爪哇转诊医院新冠肺炎患者中可溶性P选择素与血小板计数的相关性
J Blood Med. 2023 Oct 27;14:555-561. doi: 10.2147/JBM.S425667. eCollection 2023.
4
Retinal tissue and microvasculature loss in COVID-19 infection.新冠病毒感染导致的视网膜组织和微血管损伤。
Sci Rep. 2023 Mar 29;13(1):5100. doi: 10.1038/s41598-023-31835-x.
5
Association between Brain Injury Markers and Testosterone in Critically-Ill COVID-19 Male Patients.重症 COVID-19 男性患者脑损伤标志物与睾酮之间的关联
Microorganisms. 2022 Oct 22;10(11):2095. doi: 10.3390/microorganisms10112095.
6
Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Can Predict the Severity in COVID-19 Patients from Ethiopia: A Retrospective Study.中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值可预测埃塞俄比亚新冠肺炎患者的病情严重程度：一项回顾性研究
Int J Gen Med. 2022 Oct 7;15:7701-7708. doi: 10.2147/IJGM.S383558. eCollection 2022.
7
Neutrophil-to-Lymphocyte Ratio and Cut-off Values as Predictor of Severity and Mortality in COVID-19 Patients in Millennium COVID-19 Care Center, Addis Ababa, Ethiopia.埃塞俄比亚亚的斯亚贝巴千禧新冠护理中心新冠患者中性粒细胞与淋巴细胞比值及临界值作为病情严重程度和死亡率预测指标的研究
Int J Gen Med. 2022 Aug 23;15:6739-6755. doi: 10.2147/IJGM.S375565. eCollection 2022.
8
The Level of vWF Antigen and Coagulation Markers in Hospitalized Patients with Covid-19.新冠病毒病住院患者血管性血友病因子抗原及凝血标志物水平
J Blood Med. 2021 Aug 30;12:809-817. doi: 10.2147/JBM.S318940. eCollection 2021.
新冠后综合征（PC19S）：慢性反应性内皮炎与播散性血管疾病
Acta Med Port. 2020 Dec 2;33(12):859. doi: 10.20344/amp.14612.
4
Role of endothelial dysfunction in the thrombotic complications of COVID-19 patients.内皮功能障碍在新冠病毒肺炎患者血栓形成并发症中的作用
J Infect. 2021 May;82(5):186-230. doi: 10.1016/j.jinf.2020.11.041. Epub 2020 Dec 2.
5
COVID-19 and thrombosis: Beyond a casual association.新型冠状病毒肺炎与血栓形成：不仅仅是偶然关联。
Med Clin (Barc). 2020 Jul 10;155(1):44. doi: 10.1016/j.medcli.2020.04.014. Epub 2020 May 11.
6
COVID-19: the vasculature unleashed.COVID-19：血管失控。
Nat Rev Immunol. 2020 Jul;20(7):389-391. doi: 10.1038/s41577-020-0343-0.